1. Home
  2. NVEC vs NGNE Comparison

NVEC vs NGNE Comparison

Compare NVEC & NGNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NVE Corporation

NVEC

NVE Corporation

HOLD

Current Price

$66.93

Market Cap

328.9M

Sector

Technology

ML Signal

HOLD

Logo Neurogene Inc.

NGNE

Neurogene Inc.

HOLD

Current Price

$17.74

Market Cap

327.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NVEC
NGNE
Founded
1989
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
328.9M
327.8M
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
NVEC
NGNE
Price
$66.93
$17.74
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$38.50
AVG Volume (30 Days)
60.4K
184.1K
Earning Date
01-21-2026
11-13-2025
Dividend Yield
6.13%
N/A
EPS Growth
N/A
N/A
EPS
2.85
N/A
Revenue
$24,784,396.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$22.82
N/A
Revenue Growth
N/A
N/A
52 Week Low
$51.50
$6.88
52 Week High
$84.64
$37.27

Technical Indicators

Market Signals
Indicator
NVEC
NGNE
Relative Strength Index (RSI) 57.61 42.06
Support Level $62.67 $16.47
Resistance Level $65.45 $18.94
Average True Range (ATR) 2.15 1.47
MACD 0.42 -0.03
Stochastic Oscillator 87.82 23.47

Price Performance

Historical Comparison
NVEC
NGNE

About NVEC NVE Corporation

NVE Corp develops and sells devices that use spintronics, a nanotechnology that relies on electron spin. It manufactures high-performance spintronic products including sensors and couplers that are used to acquire and transmit data. The company's products include Digital sensors, Medical sensors, Rotation Sensors, GT Sensors, Angle Sensors, Analog sensors, MSOP Isolators, Passive-In Transceivers, and others. The company manufactures high-performance spintronic products including sensors and couplers. The company's designs are based on giant magnetoresistance GMR and tunneling magnetoresistance TMR combined with integrated circuitry.

About NGNE Neurogene Inc.

Neurogene Inc is a clinical-stage biotechnology company committed to overcoming the limitations of neurological diseases into treatable conditions, by harnessing its proprietary transgene regulation technology, EXACTTM (Expression Attenuation via Construct Tuning). It is building a differentiated product portfolio of genetic medicines for rare neurological diseases with high unmet needs. The drug candidates in the company's product pipeline include NGN-401, which is in development for the treatment of Rett syndrome, using its EXACT platform, and NGN-101, a non-EXACT, conventional gene therapy development candidate for the treatment of CLN5 Batten disease, designed to deliver the CLN5 gene and packaged in an AAV9 capsid.

Share on Social Networks: